Exploring RNA modifications to revolutionise cancer care
The European Epitranscriptomics of Cancer Academy (EURECA) Network is a Marie Skłodowska-Curie Actions Doctoral Network (MSCA-DN) funded by the European Union.
EURECA is a training and research programme focused on RNA modifications in cancer. These chemical changes to RNA, once overlooked, are now recognised as important drivers of cancer initiation and progression. By studying them, EURECA researchers aim to improve early detection, prediction, and treatment focusing on prostate cancer, neuroblastoma and glioma.
Open PhD position available here
